Table 3 Patient characteristics and results of survival analysis for primary glioblastoma patients when stratified by MGMT methylation status
Overall survival | MGMT methylation status | ||||
|---|---|---|---|---|---|
Total | qMSP | Pyrosequencing | |||
Methylated | Unmethylated | Methylated | Unmethylated | ||
Patients (n) | 58 | 19 | 39 | 29 | 29 |
Male/Female | 31/27 | 10/9 | 21/18 | 15/14 | 16/13 |
Mean agea (Standard deviation) | 58.5 (9.1) | 57.5 (8.7) | 59.0 (9.3) | 59.3 (8.5) | 57.7 (9.7) |
Median survivalb (Standard error) | 13.1 (1.1) | 17.6 (4.2) | 12.2 (1.0) | 16.1 (3.7) | 11.5 (0.4) |
2-years overall survival (%) (Standard error) | 21.8 (0.06) | 35.5 (0.11) | 15.4 (0.06) | 33.6 (0.09) | 10.3 (0.06) |